Details for New Drug Application (NDA): 022206

✉ Email this page to a colleague

NDA 022206 describes RAPAFLO, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the RAPAFLO profile page.

The generic ingredient in RAPAFLO is silodosin. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the silodosin profile page.

Summary for 022206

Tradename:	RAPAFLO
Applicant:	Allergan
Ingredient:	silodosin
Patents:	0

Pharmacology for NDA: 022206

Mechanism of Action	Adrenergic alpha-Antagonists

Suppliers and Packaging for NDA: 022206

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
RAPAFLO	silodosin	CAPSULE;ORAL	022206	NDA	Allergan, Inc.	0023-6142	0023-6142-30	30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6142-30)
RAPAFLO	silodosin	CAPSULE;ORAL	022206	NDA	Allergan, Inc.	0023-6147	0023-6147-30	30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6147-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	4MG
Approval Date:	Oct 8, 2008	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	8MG
Approval Date:	Oct 8, 2008	TE:	AB	RLD:	Yes

Expired US Patents for NDA 022206

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-001	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-001	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-001	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-002	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-002	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-002	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
Allergan	RAPAFLO	silodosin	CAPSULE;ORAL	022206-002	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.